p53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate Academic Article Article uri icon

Overview

MeSH Major

  • Biopsy, Needle
  • Evidence-Based Medicine
  • Neoplasm Invasiveness
  • Soft Tissue Neoplasms

abstract

  • Alterations of the p53/MDM2 pathway are frequent in OS and usually represent mutually exclusive tumorigenic events. p53 does not appear to be a major determinant of proliferative rate in OS.

publication date

  • April 15, 1997

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1002/(SICI)1097-0142(19970415)79:8<1541::AID-CNCR15>3.0.CO;2-Y

PubMed ID

  • 9118036

Additional Document Info

start page

  • 1541

end page

  • 7

volume

  • 79

number

  • 8